Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Ibogaine Treatment Centers as Solution to Toronto’s Drug Crisis

Toronto, ON - August 22, 2024 - David Dardashti, a leading advocate for ibogaine therapy, today announced his proposal to utilize ibogaine as a key tool in combating the escalating drug crisis in Toronto. Dardashti believes that ibogaine, a naturally occurring psychoactive substance, has the potential to revolutionize addiction treatment and help countless individuals overcome their dependence on opioids and other drugs.

Toronto, like many cities across the globe, is grappling with a devastating drug epidemic. The city has seen a dramatic increase in overdose deaths in recent years, fueled largely by the widespread availability of fentanyl and other synthetic opioids. Traditional treatment methods have proven insufficient in addressing this crisis, leading to a growing demand for innovative and effective solutions.

Ibogaine has shown remarkable promise in interrupting addiction cycles and facilitating long-term recovery. Clinical studies and anecdotal evidence suggest that ibogaine can significantly reduce withdrawal symptoms, cravings, and the risk of relapse. By targeting the root causes of addiction, ibogaine offers a unique and potentially transformative approach to treatment.

"Ibogaine is not a magic bullet, but it represents a powerful tool in our fight against addiction," said David Dardashti. "By harnessing the potential of ibogaine, we can provide individuals with a safe and effective pathway to recovery, ultimately saving lives and strengthening communities across Toronto."

Dardashti's proposal includes the following key elements:

  • Expanding access to ibogaine treatment: Dardashti advocates for the establishment of licensed ibogaine clinics throughout Toronto, ensuring that individuals have access to safe and supervised treatment.

  • Integrating ibogaine into existing treatment programs: Ibogaine can be incorporated into comprehensive treatment plans, complementing traditional therapies and enhancing overall outcomes.

  • Conducting further research: While the existing evidence is promising, continued research is essential to fully understand the benefits and risks of ibogaine therapy.


Dardashti's proposal has garnered support from various addiction treatment professionals, community leaders, and individuals in recovery. However, it is also important to acknowledge that ibogaine is not without its risks and challenges. Careful regulation and oversight are crucial to ensure the safe and responsible use of this substance.

Dardashti remains optimistic about the potential of ibogaine to make a significant impact on Toronto's drug crisis. "It's time to explore every available option in our quest to combat addiction," he said. "Ibogaine represents a beacon of hope for those struggling with substance abuse, and I am committed to working tirelessly to make this treatment accessible to all who need it."

About David Dardashti:

David Dardashti is a passionate advocate for ibogaine therapy and has dedicated his life to helping individuals overcome addiction. He is the founder of his organization, which provides education and resources about ibogaine treatment.

Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email: Send Email
Country: United States
Website: www.ibogaineclinic.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.